Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy

The aim of the work described here was to evaluate the role of contrast-enhanced ultrasound (CEUS) in response evaluation for unresectable advanced hepatocellular carcinoma (HCC) treated with tyrosine kinase inhibitors (TKIs) plus anti-programmed cell death protein-1 (PD-1) antibody therapy.

Source: Ultrasound in Medicine and Biology - October 16, 2023 Category: Radiology Authors: Chong-Ke Zhao, Xin Guan, Yin-Ying Pu, Bo-Yang Zhou, Li-Fan Wang, Yi-Kang Sun, Hao-Hao Yin, Han-Sheng Xia, Xi Wang, Hong Han, Hui-Xiong Xu Tags: Original Contribution Source Type: research